STAT3 and hepatocellular carcinoma: Other investigators have elucidated the potential of HAMP as a diagnostic biomarker for HCC from the perspectives of HAMP-SLC40A1 signaling, cyclin4-dependent kinase-1/STAT3 pathway and Circ_0004913 [33,34,35].